VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DaiS who wrote (9457)	6/10/1998 7:52:00 AM
From: blankmind	Read Replies (1) of 23519

Dais - great post - Let's face it. Viagra & Pfizer are going to be #1 in every country. - However, Vivus will be a niche player in every country. - Whether it's only 5,000, 10,000, or 15,000 scripts per country, times 50 or 60 countries, and then we're not talking $2 per share anymore. We're talking $3 or $4. - I hate to be a broken record. But I believe the shorts are toast.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next